Search

Search Constraints

You searched for: Author/Creator Witte, Torsten

Search Results

2. 188 Real-world data on the use of certolizumab pegol for the treatment of axial spondyloarthritis in clinical practice in Europe: 24-week interim results from a prospective non-interventional cohort study. (25th April 2018)

3. A replication study confirms the association of TNFSF4 (OX40L) polymorphisms with systemic sclerosis in a large European cohort. Issue 4 (27th December 2010)

4. AB0698 EFFECTIVENESS AND SAFETY OF CERTOLIZUMAB PEGOL FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS IN REAL-WORLD CLINICAL PRACTICE IN EUROPE: RESULTS FROM A PROSPECTIVE NON-INTERVENTIONAL 12-MONTH COHORT STUDY. (June 2019)

5. Analysis of the REL polymorphism rs13031237 in autoimmune diseases. Issue 4 (27th September 2010)

6. Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammation. (4th July 2022)

8. Anti-MYC-associated zinc finger protein antibodies are associated with inflammatory atherosclerotic lesions on 18F-fluorodeoxyglucose positron emission tomography. (April 2017)

9. B cell depletion impairs vaccination-induced CD8+ T cell responses in a type I interferon-dependent manner. Issue 12 (5th July 2021)

10. Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross‐Disease Meta‐Analysis of Genome‐Wide Association Studies. Issue 9 (25th August 2016)